{"id":"https://openalex.org/A5116765490","orcid":"https://orcid.org/0009-0009-7039-538X","observed_orcids":["https://orcid.org/0009-0009-7039-538X"],"display_name":"Emma Ingan\u00e4s","raw_author_names":["Emma Ingana\u0308s","Emma Ingan\u00e4s","Ingan\u00e4s, Emma"],"full_name":"Emma Ingan\u00e4s","works_count":5,"cited_by_count":9,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5116765490","orcid":"https://orcid.org/0009-0009-7039-538X","observed_orcids":["https://orcid.org/0009-0009-7039-538X"]},"affiliations":[{"institution":{"id":"https://openalex.org/I881427289","ror":"https://ror.org/01tm6cn81","display_name":"University of Gothenburg","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I881427289","ror":"https://ror.org/01tm6cn81","display_name":"University of Gothenburg","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":3,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","count":2,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10407","display_name":"Lipid Membrane Structure and Behavior","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":6.56e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","value":8.2e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","value":8e-06,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","value":7.9e-06,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":7.3e-06,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.880299985408783},{"id":"12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","score":0.6446999907493591},{"id":"2778106830","wikidata":"https://www.wikidata.org/wiki/Q29548","display_name":"Cell membrane","score":0.4788999855518341},{"id":"2992270614","wikidata":"https://www.wikidata.org/wiki/Q29548","display_name":"Membrane permeability","score":0.46869999170303345},{"id":"1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","score":0.45840001106262207}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":1},{"year":2026,"works_count":3,"oa_works_count":2,"cited_by_count":8}],"display_name_alternatives":["Emma Ingana\u0308s","Emma Ingan\u00e4s","Ingan\u00e4s, Emma"],"block_key":"e inganas","works_api_url":"https://api.openalex.org/works?filter=author.id:A5116765490","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5116765490","updated_date":"2026-11-17T13:41:00","created_date":"2025-10-10T00:00:00"}
